m+Medelevator.RU
← Поиск публикаций
Immunity · 2017

25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model.

СтатьяПоддержка исследования: вне правительства СШАПоддержка правительства СШАПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Li Chunfeng, Deng Yong-Qiang, Wang Shuo, Ma Feng, Aliyari Roghiyh, Huang Xing-Yao, Zhang Na-Na, Watanabe Momoko, Dong Hao-Long, Liu Ping, Li Xiao-Feng, Ye Qing, Tian Min, Hong Shuai, Fan Junwan, Zhao Hui, Li Lili, Vishlaghi Neda, Buth Jessie E, Au Connie, Liu Ying, Lu Ning, Du Peishuang, Qin F Xiao-Feng, Zhang Bo, Gong Danyang, Dai Xinghong, Sun Ren, Novitch Bennett G, Xu Zhiheng, Qin Cheng-Feng, Cheng Genhong

Аннотация

Zika virus (ZIKV) has become a public health threat due to its global transmission and link to severe congenital disorders. The host immune responses to ZIKV infection have not been fully elucidated, and effective therapeutics are not currently available. Herein, we demonstrated that cholesterol-25-hydroxylase (CH25H) was induced in response to ZIKV infection and that its enzymatic product, 25-hydroxycholesterol (25HC), was a critical mediator of host protection against ZIKV. Synthetic 25HC addition inhibited ZIKV infection in vitro by blocking viral entry, and treatment with 25HC reduced viremia and conferred protection against ZIKV in mice and rhesus macaques. 25HC suppressed ZIKV infection and reduced tissue damage in human cortical organoids and the embryonic brain of the ZIKV-induced mouse microcephaly model. Our findings highlight the protective role of CH25H during ZIKV infection and the potential use of 25HC as a natural antiviral agent to combat ZIKV infection and prevent ZIKV-associated outcomes, such as microcephaly.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты